These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9156270

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Myasthenia gravis after allogeneic bone marrow transplantation.
    Shimoda K, Gondo H, Harada M, Sano T, Nakamura M, Otsuka T, Okamura S, Niho Y.
    Bone Marrow Transplant; 1994 Jul; 14(1):155-6. PubMed ID: 7951105
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A patient of chronic graft-versus-host disease presenting simultaneously with polymyositis and myasthenia gravis].
    Yanagihara C, Nakaji K, Tanaka Y, Yabe H, Nishimura Y.
    Rinsho Shinkeigaku; 2001 Aug; 41(8):503-6. PubMed ID: 11889835
    [Abstract] [Full Text] [Related]

  • 7. Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma.
    Dowell JE, Moots PL, Stein RS.
    Bone Marrow Transplant; 1999 Dec; 24(12):1359-61. PubMed ID: 10627649
    [Abstract] [Full Text] [Related]

  • 8. Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation.
    Heidarzadeh Z, Mousavi SA, Ostovan VR, Nafissi S.
    Neuromuscul Disord; 2014 Feb; 24(2):148-50. PubMed ID: 24314584
    [Abstract] [Full Text] [Related]

  • 9. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease.
    Tse S, Saunders EF, Silverman E, Vajsar J, Becker L, Meaney B.
    Bone Marrow Transplant; 1999 Feb; 23(4):397-9. PubMed ID: 10100585
    [Abstract] [Full Text] [Related]

  • 10. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 11. Late onset post-transplantation lymphoproliferative disease of recipient origin following cytogenetic relapse and occult autologous haematopoietic regeneration after allogeneic bone marrow transplantation for acute myeloid leukaemia.
    Au WY, Lie AK, Lee CK, Ma SK, Wan TS, Shek TW, Liang R, Kwong YL.
    Bone Marrow Transplant; 2001 Aug; 28(4):417-9. PubMed ID: 11571518
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Myasthenia gravis after allogeneic bone marrow transplantation: a case report.
    Zaja F, Russo D, Silvestri F, Barillari G, Fanin R, Cerno M, Marchini C, Baccarani M.
    Bone Marrow Transplant; 1995 Apr; 15(4):649-50. PubMed ID: 7655397
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E, Nagler A, Or R, Kapelushnik J, Slavin S.
    Clin Transpl; 1996 Apr; ():281-90. PubMed ID: 9286578
    [Abstract] [Full Text] [Related]

  • 20. [Neuromuscular complications after allogeneic bone marrow transplantation].
    Padovan CS, Sostak P, Reich P, Kolb HJ, Müller-Felber W, Straube A.
    Nervenarzt; 2003 Feb; 74(2):159-66. PubMed ID: 12596017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.